Role of N-2 hydroxyethyl-piperazine-N'-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury

Details for Australian Patent Application No. 2010295445 (hide)

Owner North Texas Medical Associates

Inventors Danhof, Ivan E.

Agent Pizzeys

Pub. Number AU-A-2010295445

PCT Pub. Number WO2011/035212

Priority 61/243,464 17.09.09 US

Filing date 17 September 2010

Wipo publication date 24 March 2011

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/035212 Priority application(s): WO2011/035212

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010295447-Hair restoration surgery

2010295431-Wine aerator tower